153 related articles for article (PubMed ID: 22051340)
1. Diabetogenic T lymphocytes in human Type 1 diabetes.
Roep BO; Peakman M
Curr Opin Immunol; 2011 Dec; 23(6):746-53. PubMed ID: 22051340
[TBL] [Abstract][Full Text] [Related]
2. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
3. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
4. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
5. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cells in type 1 diabetes.
Juedes AE; von Herrath MG
Diabetes Metab Res Rev; 2004; 20(6):446-51. PubMed ID: 15386802
[TBL] [Abstract][Full Text] [Related]
7. The potential of multimer technologies in type 1 diabetes prediction strategies.
Fierabracci A
Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease.
Badenhoop K; Boehm BO
Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):407-15. PubMed ID: 15372359
[TBL] [Abstract][Full Text] [Related]
9. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
[TBL] [Abstract][Full Text] [Related]
10. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
Geenen V; Mottet M; Dardenne O; Kermani H; Martens H; Francois JM; Galleni M; Hober D; Rahmouni S; Moutschen M
Curr Opin Pharmacol; 2010 Aug; 10(4):461-72. PubMed ID: 20434402
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.
Chaturvedi P; Qin HY; Chou H; Singh B
Crit Rev Immunol; 1997; 17(5-6):519-28. PubMed ID: 9419439
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
Scherbaum WA; Seissler J
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
[TBL] [Abstract][Full Text] [Related]
14. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
[TBL] [Abstract][Full Text] [Related]
15. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
Thivolet C; Khallouf E
Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
[TBL] [Abstract][Full Text] [Related]
17. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
[TBL] [Abstract][Full Text] [Related]
18. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
20. Insulin-specific tolerance in diabetes.
Gottlieb PA; Eisenbarth GS
Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
